Clinical relevance of bcl2(MBR)IJ,H rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma
1997

Prognostic Role of bcl-2 Rearrangement in Follicular Lymphoma

Sample size: 59 publication Evidence: moderate

Author Information

Author(s): F Bertoni, G Bosshard, E Roggero, E Ceresa, F Cavalli, E Zucca

Primary Institution: Servizio Oncologico Cantonale, Ospedale San Giovanni, CH-6500 Bellinzona, Switzerland

Hypothesis

Does the detection of bcl-2(MBR)/JH rearrangement in peripheral blood predict outcomes in patients with follicular lymphoma?

Conclusion

The detection of bcl-2/JH rearrangement at diagnosis is not a prognostic factor in follicular lymphoma, but clearance of these cells post-treatment correlates with better overall survival.

Supporting Evidence

  • 35 of 59 patients were bcl-2/JH positive at diagnosis.
  • Clearance of bcl-2/JH-positive cells correlated with better overall survival.
  • 82% of patients who were bcl-2/JH positive at diagnosis became negative post-treatment.

Takeaway

This study looked at blood tests for a specific gene change in lymphoma patients. It found that while the gene change at diagnosis doesn't help predict how long patients will live, getting rid of it after treatment is a good sign.

Methodology

Peripheral blood samples were analyzed for bcl-2(MBR)/JH rearrangement using PCR in 59 patients with follicular lymphoma.

Limitations

The study's findings may not be generalizable due to the specific patient population and the need for longer follow-up.

Participant Demographics

Patients were HIV-negative and histologically diagnosed with follicular lymphoma.

Statistical Information

P-Value

P < 0.0001 for ECOG PS > 1 associated with reduced OS

Confidence Interval

95% CI 68-91%

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication